Coriolis Pharma Opens New Laboratory in Morrisville, NC

Coriolis Pharma, a globally operating CRDO and a leader in formulation research and development for biopharmaceuticals, announced its investment of $10 million in establishing a research laboratory at Spark LS, an innovative life science campus in Morrisville, North Carolina.

The new laboratory will be approximately 13,000 square feet and is scheduled to begin operations in the first quarter of 2026. As a strategic anchor for Coriolis Pharma’s North American expansion, the facility will initially deliver core services such as particle identification, followed by formulation development and lyophilization. 

These new offerings will be seamlessly integrated with the company’s global scientific and operational network, operating in close collaboration with its headquarters in Germany. 

The site is designed to support future innovation, including the adoption of digital and in-silico technologies, reinforcing Coriolis Pharma’s vision to accelerate and de-risk biopharmaceutical development.

Spark LS is the region’s largest mixed-use life science and innovation campus, featuring multi-functional spaces across 1.5 million square feet of laboratory and biomanufacturing space. The approximately 108-acre campus is located close to the Research Triangle Park in the Raleigh-Durham MSA. 

“With our future presence in North Carolina, we will be able to serve our North American clients even better, offering our core services quickly and efficiently on site,” said Silvia Steyrer-Gruber, Chief Executive Officer of Coriolis Pharma. “The innovative environment, proximity to numerous life science companies and excellent infrastructure around Morrisville, reinforced our decision.”

Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish their U.S. headquarters and first U.S. lab here at Spark is a testament to the innovative environment we’re cultivating and the immense potential within the region’s burgeoning biotech sector.”

In the coming months, Coriolis Pharma will advance the build-out of the North Carolina laboratory and begin hiring its first new employees.